Stemline Therapeutics Inc (NASDAQ:STML)

During the Trading Day
16.05 +0.37 / +2.36%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
16.05 0.00 / 0.00%
 
Volume: 276.00
No recent news for Stemline Therapeutics Inc.

Today’s Trading

Previous close15.68
Today’s open15.60
Day’s range15.23 - 16.25
Volume78,125
Average volume (3 months)205,353
Market cap$276.6M
Dividend yield--
Data as of 4:00pm ET, 03/04/2015

Growth & Valuation

Earnings growth (last year)-179.33%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales2,848.17
Price/Book2.58

Competitors

 Today’s
change
Today’s
% change
SVASinovac Biotech Ltd-0.02-0.40%
AMBIAmbit Biosciences Co...----
PPHMPeregrine Pharmaceut...-0.01-0.68%
CNCEConcert Pharmaceutic...-0.18-1.22%
Data as of 4:00pm ET, 03/04/2015

Financials

Next reporting dateMarch 30, 2015
EPS forecast (this quarter)-$0.60
Annual revenue (last year)$71.0K
Annual profit (last year)-$24.2M
Net profit margin-34,079.59%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Ivan Bergstein
Chief Operating Officer &
Secretary
Kenneth Hoberman
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account